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Control of growth and differentiation by Drosophila RasGAP, a
homolog of p120 Ras-GTPase-activating protein
Abstract
Mammalian Ras GTPase-activating protein (GAP), p120 Ras-GAP, has been implicated as both a
downregulator and effector of Ras proteins, but its precise role in Ras-mediated signal transduction
pathways is unclear. To begin a genetic analysis of the role of p120 Ras-GAP we identified a homolog
from the fruit fly Drosophila melanogaster through its ability to complement the sterility of a
Schizosaccharomyces pombe (fission yeast) gap1 mutant strain. Like its mammalian homolog,
Drosophila RasGAP stimulated the intrinsic GTPase activity of normal mammalian H-Ras but not that
of the oncogenic Val12 mutant. RasGAP was tyrosine phosphorylated in embryos and its Src homology
2 (SH2) domains could bind in vitro to a small number of tyrosine-phosphorylated proteins expressed at
various developmental stages. Ectopic expression of RasGAP in the wing imaginal disc reduced the size
of the adult wing by up to 45% and suppressed ectopic wing vein formation caused by expression of
activated forms of Breathless and Heartless, two Drosophila receptor tyrosine kinases of the fibroblast
growth factor receptor family. The in vivo effects of RasGAP overexpression required intact SH2
domains, indicating that intracellular localization of RasGAP through SH2-phosphotyrosine interactions
is important for its activity. These results show that RasGAP can function as an inhibitor of signaling
pathways mediated by Ras and receptor tyrosine kinases in vivo. Genetic interactions, however,
suggested a Ras-independent role for RasGAP in the regulation of growth. The system described here
should enable genetic screens to be performed to identify regulators and effectors of p120 Ras-GAP.
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Mammalian Ras GTPase-activating protein (GAP), p120 Ras-GAP, has been implicated as both a down-
regulator and effector of Ras proteins, but its precise role in Ras-mediated signal transduction pathways is
unclear. To begin a genetic analysis of the role of p120 Ras-GAP we identified a homolog from the fruit fly
Drosophila melanogaster through its ability to complement the sterility of a Schizosaccharomyces pombe (fission
yeast) gap1 mutant strain. Like its mammalian homolog, Drosophila RasGAP stimulated the intrinsic GTPase
activity of normal mammalian H-Ras but not that of the oncogenic Val12 mutant. RasGAP was tyrosine
phosphorylated in embryos and its Src homology 2 (SH2) domains could bind in vitro to a small number of
tyrosine-phosphorylated proteins expressed at various developmental stages. Ectopic expression of RasGAP in
the wing imaginal disc reduced the size of the adult wing by up to 45% and suppressed ectopic wing vein
formation caused by expression of activated forms of Breathless and Heartless, two Drosophila receptor
tyrosine kinases of the fibroblast growth factor receptor family. The in vivo effects of RasGAP overexpression
required intact SH2 domains, indicating that intracellular localization of RasGAP through SH2-phosphoty-
rosine interactions is important for its activity. These results show that RasGAP can function as an inhibitor
of signaling pathways mediated by Ras and receptor tyrosine kinases in vivo. Genetic interactions, however,
suggested a Ras-independent role for RasGAP in the regulation of growth. The system described here should
enable genetic screens to be performed to identify regulators and effectors of p120 Ras-GAP.
The Ras family of small GTPases play pivotal roles in the
regulation of signal transduction pathways downstream of re-
ceptor tyrosine kinases (RTKs), G protein-coupled receptors,
and cytokine receptors. Ras proteins cycle between the inactive
GDP-bound state and the active GTP-bound conformation
that interacts with downstream effector proteins such as the
Raf family of protein kinases and phosphoinositide 39-kinase
(42). This GTPase cycle is regulated by guanine nucleotide
exchange factors (GEFs) that activate Ras by stimulating re-
lease of GDP and binding to GTP and by GTPase-activating
proteins (GAPs) that inhibit Ras by increasing the intrinsic
rate of GTP hydrolysis (5).
Three types of GAP protein for Ras have been identified in
mammalian cells: p120 Ras-GAP (64, 68), neurofibromin (the
product of the human tumor suppressor gene NF1) (46, 71),
and two closely related proteins, Gap1m (45) and Gap1IP4B
(16). Although it is clear that all three types can act as GAPs
and thus inhibit the activity of Ras proteins, p120 Ras-GAP has
been also implicated as an effector of Ras. Notably, p120
Ras-GAP has an amino-terminal region similar in structural
organization to “adapter” proteins. This region contains Src
homology 2 and 3 (SH2 and SH3) domains involved in inter-
actions with other proteins and pleckstrin homology (PH) and
C2 (or CalB) domains that may promote membrane associa-
tion by binding to phospholipids (31, 56). Studies using mam-
malian tissue culture cells suggest a role for the SH2 and SH3
domains of p120 Ras-GAP in cell transformation, changes in
gene expression, K1 channel opening, and cytoskeletal rear-
rangements, and in Xenopus oocytes there is evidence that the
SH3 domain of p120 Ras-GAP is required for meiotic matu-
ration in response to Ras or insulin (63).
The identification of proteins that bind to the amino-termi-
nal adapter-like region of p120 Ras-GAP has provided further
evidence that it has roles independent of its GAP activity. The
SH2 domains bind to certain plasma membrane-associated
RTKs such as the platelet-derived growth factor b receptor (2)
and to the cytosolic proteins p190 Rho-GAP (59) and p62dok,
a “docking” protein of unknown function (10, 72). Proteins
that bind to the SH3 domain of p120 Ras-GAP have proved
difficult to identify but G3BP, a cytoplasmic protein that con-
tains RNA binding motifs, may be such an SH3 ligand (55).
The biochemical and physiological consequences of the inter-
action of p120 Ras-GAP with these proteins are poorly under-
stood.
An important advance in understanding the physiological
roles of p120 Ras-GAP has come from the analysis of mice
carrying a null mutation in the gene for p120 Ras-GAP (Gap)
(36). Embryos homozygous for this mutation die in utero with
abnormal vasculature and increased apoptosis in the nervous
system. Fibroblasts from Gap2/2 embryos can proliferate
in vitro and show enhanced accumulation of Ras-GTP upon
growth factor stimulation (67). This genetic analysis shows that
p120 Ras-GAP is not necessary for mitogenesis, at least for
most cell types, but is required to downregulate Ras following
exposure to growth factors and to protect neuronal cells from
apoptosis. Whether p120 Ras-GAP is involved in other Ras-
regulated processes such as cell migration or differentiation is
unresolved.
To study the role of p120 Ras-GAP in a genetically tractable
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organism we set out to identify a homolog from the fruit fly
Drosophila melanogaster, which has proved to be a powerful
model system for the genetic analysis of Ras signaling path-
ways (19, 41). Using an expression cloning strategy in the
fission yeast Schizosaccharomyces pombe we cloned a cDNA
encoding Drosophila RasGAP, which is similar in both se-
quence and biochemical properties to mammalian p120 Ras-
GAP. Although loss-of-function mutations in the Drosophila
RasGAP gene are not available we have begun to analyze its
function in vivo by ectopic expression. We show that overex-
pression of RasGAP in the wing imaginal disc downregulates
signaling through RTKs and inhibits wing growth. The system
we have developed will prove useful in understanding the phys-
iological role of RasGAP and the function of each of its mod-
ular domains.
MATERIALS AND METHODS
Methods for S. pombe. Yeast extract supplements (YES) and Edinburgh min-
imal medium (EMM) were used for growth of S. pombe cultures (49), and
synthetic sporulation agar (SSA) was used to promote mating and sporulation
(22). The gap1 mutant strain JZ446 (h90 gap1::ura41 ade6-M216 leu1 ura4-D18)
(40) was used in the screen for the identification of novel GTPase-activating
proteins and was transformed by the lithium acetate method (53). Plasmids were
rescued from yeast into Escherichia coli as described previously (49).
Isolation of a full-length RasGAP cDNA and plasmid constructions. The
RasGAP cDNA isolated in the yeast screen (RasGAP78) was truncated at the 59
end and predicted to initiate translation at Met266. Through screening a lgt10
embryonic cDNA library (Stratagene) and by rapid amplification of cDNA ends
(RACE) PCR with Drosophila polyA1 RNA (Clontech) as template for the
Marathon cDNA Amplification Kit (Clontech), a cDNA including 291 bp of 59
untranslated sequence was assembled. A myc tag epitope recognized by the 9E10
monoclonal antibody, followed by two TAA termination codons, was engineered
at the C terminus of the open reading frame by using the Exsite Mutagenesis Kit
(Stratagene). To generate the GAP catalytic domain construct, RasGAPCat, the
C-terminal 443 codons were amplified with a sense primer incorporating an NcoI
site which was used to fuse the resulting PCR product in-frame to the first 85
codons of the RasGAP cDNA, just N terminal to the first SH2 domain. The
full-length cDNA and the C terminus myc-tagged constructs were subcloned as
NotI fragments into the Drosophila expression vector pUAST (6) and the
S. pombe expression vector pREPCD1 (24), a derivative of the pREP1 plasmid
with a NotI site in the polylinker (47). The C-terminal part of RasGAP (amino
acids 429 to 954) was cloned as a ClaI/BamHI fragment into the E. coli expres-
sion vector pGEX-KG (33). The SH2-SH3-SH2 region (amino acids 83 to 343)
and the N-terminal SH2 domain (amino acids 83 to 182) were amplified by PCR
and cloned as XbaI/XhoI fragments into pGEX-KG. Missense mutations were
introduced by PCR-mediated mutagenesis (37) into each SH2 domain, changing
a highly conserved Arg residue to Leu (amino acid 110 in the N-terminal domain
and amino acid 278 in the C-terminal domain) to give the GST-SH2*32* mutant
and the RasGAPSH2* mutant. Sequences of the oligonucleotides used for PCR
and site-directed mutagenesis are available upon request from the corresponding
author. All PCR-derived fragments were sequenced to ensure that no mutations
were introduced. Sequences were determined with oligonucleotide primers with
the TaqFS Terminator Cycle Sequencing Kit on an ABI 377 DNA sequencer
(Applied Biosystems) and were analyzed using the Genetics Computer Group
package (32). The UAS-tor4021-btl and UAS-tor4021-htl constructs were generated
by using KpnI and XbaI to remove the fusion genes from P[sE-tor4021-FGFR1]
and P[sE-tor4021-FGFR2], respectively (57), and the inserts were subcloned into
pUAST.
General biochemical and immunological techniques. Protein samples were
separated by sodium dodecyl sulfate (SDS)-polyacrylamide electrophoresis
(PAGE) and electroblotted to Immobilon membranes (NEN) as previously de-
scribed (35). Anti-RasGAP antibody incubations were for 1 to 2 h in 5%
skimmed milk–TBST (25 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.1% Tween-20)
with washes in TBST. Antiphosphotyrosine blots were blocked in 3% bovine
serum albumin (BSA)–TBST at room temperature for 1 to 2 h, incubated over-
night at 4°C with the primary antibody 4G10 (Upstate Biotechnology) at a
concentration of 0.3 mg/ml in 3% BSA–TBST, and washed in TBST. Horseradish
peroxidase-conjugated secondary antibodies and enhanced chemiluminescence
substrates were used as recommended by the manufacturer (Pierce). Protease
inhibitors were the Complete mix (Boehringer Mannheim) together with 1 mM
phenylmethylsulfonyl fluoride.
Purification of GST fusion proteins and preparation of antibodies. Glutathi-
one S-transferase (GST) fusion proteins were expressed in E. coli by induction
with 0.5 mM isopropyl-1-thio-b-D-galactopyranoside for 2 to 4 h at 37°C. To
purify wild-type and Val12 H-Ras GST fusion proteins (69), cells were resus-
pended in TMD buffer (50 mM Tris-HCl [pH 7.5], 5 mM MgCl2, 1 mM dithio-
threitol) plus protease inhibitors and lysozyme added to a concentration of 1 mg/
ml, and the cell suspension was incubated for 20 min at 4°C. Cells were lysed by
adding Triton X-100 and DNase I to concentrations of 0.5% and 20 mg/ml,
respectively, and the lysate was incubated for 20 min at 4°C. Following centrif-
ugation at 12,000 3 g for 15 min, the supernatants were mixed with glutathione-
Sepharose beads and washed extensively with TMD, and the fusion proteins were
eluted with 50 mM Tris-HCl (pH 8.0)–5 mM MgCl2–10 mM reduced glutathi-
one. The purified proteins were dialyzed against TMD and stored in aliquots at
270°C. The GST-SH232 and GST-NSH2 fusion proteins were purified by glu-
tathione-Sepharose affinity chromatography following solubilization with N-lau-
roylsarcosine (26). The purified GST-NSH2 fusion protein was dialyzed against
phosphate-buffered saline and used to raise rat monoclonal antibodies by using
standard protocols (35). The GST-RasGAP C-terminal region was purified with
glutathione-Sepharose beads following solubilization with N-lauroylsarcosine,
and the insoluble RasGAP polypeptide was released from the fusion protein by
cleavage with thrombin. Following SDS-PAGE purification the RasGAP poly-
peptide was used to immunize a rabbit by using standard protocols (35). The
rabbit polyclonal antibody was purified by applying the crude antiserum to the
GST-fusion protein cross-linked to glutathione-Sepharose resin (3) and eluting
the bound immunoglobulin with 100 mM glycine, pH 2.5 (35). The purified
antibody was titered to determine its optimum concentration for Western blot-
ting and immunoprecipitation.
Immunoprecipitations and GST pull-downs from Drosophila cell extracts.
Soluble extracts from Drosophila embryos, larvae, pupae, and adults in Nonidet
P-40 (NP-40) lysis buffer plus protease inhibitors were prepared as previously
described (15). For immunoprecipitations, 0.1% SDS–0.5% deoxycholate were
added to the extracts and 1 mg of protein was incubated with the purified
anti-RasGAP antibody for 2 h followed by incubation with protein G-Sepharose
for 1 h. The beads were washed three times in the same buffer before analysis by
SDS-PAGE and Western blotting. For pull-downs with GST-SH232 fusion pro-
teins, cell extracts (0.5 mg of protein) were incubated with the fusion proteins (10
mg) bound to glutathione-Sepharose for 1 h at 4°C, washed three times in lysis
buffer, and analyzed by SDS-PAGE and Western blotting.
Immunostaining of embryos. Embryos were dechorionated, fixed with 4%
paraformaldehyde, devitellinized in methanol, and incubated with antibodies as
previously described (73). Incubation was overnight with the anti-RasGAP
monoclonal antibody (1/2 diluted tissue culture supernatant) and for 2 h with
Cy3-conjugated anti-rat immunoglobulin G (IgG) (Jackson ImmunoResearch).
Images were collected with a BioRad MRC-1024 confocal laser scanning micro-
scope and assembled in Adobe Photoshop 4.0.
GAP assay. S. pombe cell extracts were prepared from the gap1 mutant strain
JZ446 transformed with a vector plasmid (pREPCD1) or the full-length
RasGAP cDNA in pREPCD1 by vortexing with glass beads in 50 mM HEPES
[pH 7.4]–100 mM NaCl–5 mM MgCl2–1 mM sodium phosphate (pH 7.4)–1-
mg/ml BSA plus protease inhibitors. Following centrifugation at 15,000 3 g for
15 min, the supernatant was concentrated to ;20-mg/ml protein by ultrafiltration
(Centricon 30; Amicon). GAP assays were performed by a method described
previously (20) with [a-32P]GTP-loaded GST-Ras or GST-RasV12 fusion pro-
teins and separation of GTP and GDP bound to Ras by thin-layer chromatog-
raphy, except that following the incubation with cell extract the GST-Ras fusion
proteins were purified with glutathione-Sepharose. A PhosphorImager (Molec-
ular Dynamics) was used to image and quantify the [a-32P]-labeled guanine
nucleotides, and the percent GTP remaining was calculated as 100(GTP/GDP 1
GTP).
Drosophila stocks and phenotypic analysis. Flies were raised and crossed at
25°C according to standard procedures. Transgenic lines were made by P ele-
ment-mediated transformation into a y w stock. The GAL4 lines used were
MS-1096 (X chromosome) for expression in the dorsal pouch of the wing disc (9)
and hsp70-GAL4 (3rd chromosome) for expression upon heat shocking (51). The
Ras1e2F mutant allele was used (60). Wings were dissected, dehydrated in etha-
nol, and mounted in Euparal (Agar Scientific). Photographs of wings were
digitized with a flat-bed scanner, processed in Adobe Photoshop 4.0, and ana-
lyzed using NIH Image 1.60 software.
Nucleotide sequence accession number. The RasGAP cDNA nucleotide se-
quence has been submitted to the EMBL database under accession no.
AJ012609.
RESULTS
Expression cloning in fission yeast of a Drosophila p120 Ras-
GAP homolog. An expression cloning screen with S. pombe was
devised to identify inhibitors of Ras function from D. melano-
gaster. In S. pombe, mutation of the gap1 gene (also known
as sar1), which encodes a member of the RasGAP family of
proteins, results in hypersensitivity to mating pheromones, for-
mation of extended mating projections, and inefficient mating
(Fig. 1A, i, and 1B, i) (40, 70). These phenotypes result from
hyperactivation of Ras1, the S. pombe homolog of mammalian
Ras oncoproteins, because mutations in Ras1 that inhibit its
GTPase activity cause identical effects (28, 50). We reasoned
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that expression of inhibitors of Ras function from higher or-
ganisms in a gap1 mutant strain would restore efficient mating
by downregulating the activities of Ras1-regulated signaling
pathways. Such a screen might identify both proteins that bind
directly to Ras1, such as GAPs and effectors, and proteins that
interfered with the function of downstream components of the
Ras1 signaling pathways.
To identify inhibitors of Ras from D. melanogaster, a gap1
mutant strain (JZ446) was transformed with a Drosophila em-
bryonic cDNA library constructed in the pREP expression vec-
tor (21). Sixty-thousand transformant colonies were screened
by iodine vapor staining, a qualitative indicator of mating ef-
ficiency. Dark-staining colonies were then checked microscop-
ically for the presence of zygotic asci. Two transformant colo-
nies showing efficient mating were identified, and plasmids
were rescued from them into E. coli. We confirmed that both
plasmids could suppress the gap1 mutant phenotype (Fig. 1A,
iii and 1B, iii; and data not shown). One of the plasmids carried
a cDNA insert encoding the carboxy-terminal 263 amino acids
of the Drosophila moesin homolog, a member of the ERM
(ezrin, radixin, and moesin) family (21, 66). This cDNA could
rescue the sterility of an S. pombe strain carrying an activated
ras1 allele (ras1-Val17), suggesting that it inhibits signaling
downstream of Ras1; the properties of this cDNA will be
described elsewhere (24). The second plasmid could not sup-
press the sterility of the activated ras1-Val17 mutant strain
(24), suggesting that it was acting either upstream of or directly
upon Ras1. Sequence analysis of the cDNA insert revealed
that it encoded a putative protein with significant similarity to
members of the RasGAP family, particularly to human and
bovine p120 Ras-GAPs (65, 68). Sequence alignment of the
Drosophila cDNA with mammalian p120 Ras-GAP indicated
that the cDNA was truncated at its 59 end, and a full-length
cDNA was subsequently identified (see Materials and Meth-
ods). Analysis of this Drosophila cDNA confirmed that it en-
coded a homolog of mammalian p120 Ras-GAP, which we
have named RasGAP. The predicted RasGAP protein consists
of 954 amino acids with a predicted Mr of ;108,000.
Structure of Drosophila RasGAP. Drosophila RasGAP and
human p120 Ras-GAP share 47% amino acid identity (68%
similarity) overall (Fig. 2A). Like its mammalian homologs, the
Drosophila protein can be divided into two regions. The amino-
terminal part consists of protein-protein (SH2 and SH3) and
protein-lipid (PH and C2/CalB) interaction domains. The car-
boxy-terminal part contains the GAP catalytic domain which is
conserved in RasGAPs from yeast to mammals (5).
Mammalian p120 Ras-GAP is tyrosine phosphorylated upon
activation of certain RTKs and in cells expressing non-RTKs
(23, 48). The major site of tyrosine phosphorylation in vitro by
the epidermal growth factor (EGF) receptor and the non-
RTKs Src and Lck is tyrosine 460 in human p120 Ras-GAP,
lying between the most carboxy-terminal SH2 domain and the
PH domain (1, 44, 54). A tyrosine residue in a similar posi-
tion with similar flanking sequences (IYATLR in Drosophila
RasGAP and IYNTIR in human p120 Ras-GAP) is found in
the Drosophila protein, suggesting that this is a conserved
phosphorylation site (Fig. 2A).
The structure of the RasGAP transcription unit was deter-
mined by a comparison of cDNA and genomic sequence (Fig.
2B). It consists of eight exons and seven introns; six of the
introns are small (,200 nucleotides [nt]) but one that splits the
59 untranslated region is much larger than the others (1,535
nt). The RasGAP gene was mapped to cytological position
14A-B1 on the first (X) chromosome by in situ hybridization to
polytene chromosomes (24).
FIG. 1. Complementation of the S. pombe gap1 mutant phenotype by the Drosophila RasGAP cDNA. The homothallic h90 gap1 mutant strain (JZ446) was
transformed with the vector pREPCD1 (i), pST200-1(gap11) carrying the S. pombe gap11 gene (ii), pREPRasGAP78 containing the original cDNA isolated from the
library screen (iii), pREPRasGAP containing the full-length cDNA (iv), and pREPRasGAPCat containing the GAP catalytic domain (v). A wild-type homothallic h90
strain was used as control (vi). Transformants were grown on sporulation agar (SSA) at 30°C for 3 days. Differential interference contrast microscopy (A) and iodine
staining (B), which stains spores, revealed that the three RasGAP cDNA constructs allowed the gap1 mutant strain to undergo mating and sporulation. The arrows in
panel A indicate typical zygotic asci.
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GAP activity of RasGAP. The original RasGAP cDNA (Ras
GAP78) identified in the expression cloning screen was amino-
terminally truncated and predicted to initiate at Met266. We
examined whether constructs carrying the full-length cDNA
or just the GAP catalytic domain (amino acids 553 to 954,
designated RasGAPCat) could also rescue the gap1 mutant
strain (JZ446). Both constructs could restore efficient mating
to the gap1 mutant strain (Fig. 1A, iv and v and B, iv and v) and
in fact both rescued better than overexpression of the S. pombe
gap11 gene (Fig. 1A, ii and B, ii), restoring mating to nearly
wild-type levels (Fig. 1B, vi). These results show that the
RasGAP catalytic domain is responsible for downregulation of
Ras1 activity in S. pombe. The ability of RasGAP to rescue the
Ras “hyperactivation” phenotype caused by loss of gap1 func-
tion, but not that caused by a GAP-insensitive ras1 mutant
(ras1-Val17), suggested that RasGAP was acting as a GAP on
the S. pombe Ras1 protein in vivo, rather than as a “dominant
negative” by binding to Ras1-GTP and preventing interaction
with Ras1 effector proteins.
To confirm that RasGAP has GAP activity we tested the
FIG. 2. RasGAP amino acid sequence and genomic organization of the RasGAP gene. (A) Alignment of the predicted amino acid sequence of RasGAP (top) with
human p120 Ras-GAP (bottom). The comparison was generated with the GAP program of the Genetics Computer Group package (32). P, identical amino acids; :,
amino acid pairs with Dayhoff matrix scores greater than 0.5; ., nonidentical amino acids having a positive Dayhoff matrix score of ,0.5. The SH2 domains are shown
by shading and the SH3 domain is boxed. The PH domain is underlined by a solid line and the C2/CalB domain is underlined by a dotted line. The asterisk indicates
the conserved tyrosine that is phosphorylated in human p120 Ras-GAP. (B) The exon-intron structure of the RasGAP transcription unit. The white boxes represent
noncoding regions, and the black boxes represent coding regions.
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ability of the full-length protein to stimulate the GTPase ac-
tivity of mammalian H-Ras in vitro. Cell extracts prepared from
the S. pombe gap1 mutant strain expressing full-length RasGAP
or a vector control were assayed for GAP activity on [a-32P]
GTP-loaded wild-type or Val12 (GTPase-deficient) H-Ras. The
results (Fig. 3) show that the extract expressing RasGAP stimu-
lated GTP hydrolysis on wild-type H-Ras but not on the Val12
mutant protein, consistent with the properties of the mamma-
lian GAPs (5).
Characterization of the RasGAP protein. A monoclo-
nal antibody raised against the N-terminal SH2 domain of
RasGAP detected the 108-kDa RasGAP protein by immuno-
blotting. The levels of expression of RasGAP in embryos,
larvae, and adults were assessed by immunoblotting equal
amounts of total protein from each developmental stage. This
showed that the protein is expressed throughout development
but with significantly higher levels of embryos (Fig. 4A). Im-
munostaining of embryos with the anti-RasGAP monoclonal
antibody detected staining in precellularized embryos (0 to
2 h), before zygotic transcription begins, indicating that the
RasGAP protein is supplied maternally (Fig. 4D). The RasGAP
protein was cytoplasmic and appeared to be present in all cells
at the cellular blastoderm stage (Fig. 4E).
Mammalian p120 Ras-GAP is tyrosine phosphorylated upon
activation of several RTKs and in cells expressing oncogenic
non-RTKs. To determine whether Drosophila RasGAP was
tyrosine phosphorylated in vivo, the protein was immunopre-
cipitated from embryonic extracts with a polyclonal antibody
raised against the GAP domain and Western blotted with an
antiphosphotyrosine monoclonal antibody. The result (Fig.
4B) showed that RasGAP is tyrosine phosphorylated at a
low level in vivo. However, not all the bands detected by the
antiphosphotyrosine antibody were detected with the anti-
RasGAP polyclonal antibody so that it is possible that some of
these bands are from proteins that coimmunoprecipitate with
RasGAP.
The SH2 domains of mammalian p120 Ras-GAP bind to
phosphotyrosine residues on RTKs, p190 Rho-GAP and the
docking protein p62dok (2, 10, 39, 72). To investigate whether
the SH2 domains of Drosophila RasGAP could bind to tyro-
sine-phosphorylated proteins, the region encompassing the two
SH2 domains and the intervening SH3 domain (designated
SH232) was expressed as a fusion protein in bacteria and pu-
rified to give the GST-SH232 fusion protein. As a control a
mutant version of this protein, designated GST-SH2*32*, with
an inactivating single amino acid substitution in each SH2 do-
main was also expressed in bacteria and purified. The wild-type
GST-SH232 and mutant GST-SH2*32* fusion proteins were
then used to pull down proteins from cell extracts of different
developmental stages. The precipitated proteins were separat-
ed by SDS-PAGE, and phosphotyrosine-containing proteins
were detected by immunoblotting with an antiphosphotyrosine
antibody. The results of this experiment (Fig. 4C) show that
the wild-type GST-SH232 but not the mutant GST-SH2*32*
pulls down a small number of tyrosine-phosphorylated proteins
in embryos and larvae which appear to be absent or much less
abundant in adult flies. Some of the associating proteins clearly
change in abundance or phosphorylation state during develop-
ment. The band at ;75 kDa present in larvae and pupae in
both the wild-type and mutant SH232 pull-downs was visible
on Coomassie blue staining of the blot; peptide microsequenc-
ing showed that this protein is the g-subunit of larval serum
protein 1 (Lsp1g) (24), a very abundant protein in third instar
larvae and pupae (8).
Inhibition of wing growth by ectopic RasGAP expression.
To gain insight into the in vivo role of RasGAP, we generat-
ed transgenic Drosophila expressing the full-length RasGAP
cDNA, tagged with the myc epitope, under the control of the
yeast GAL4 upstream activating sequence (UAS) (6). Several
transgenic lines were obtained by P element germ-line transfor-
mation. To determine which lines were able to express RasGAP
in a GAL4-dependent manner, we crossed the UAS-RasGAP
lines with a line expressing GAL4 under the control of a heat-
shock-regulated promoter from the Hsp70 gene. Progeny car-
rying both UAS-RasGAP and hsp70-GAL4 were heat shocked,
and the expression levels of the ectopically expressed RasGAP
were analyzed by Western blotting of whole-fly lysates with
both the anti-RasGAP polyclonal antibody and the anti-myc
antibody (24). On the basis of this analysis, we selected three
independent UAS-RasGAP lines expressing the transgene at
different levels for further experiments. The UAS-RasGAP
lines were crossed to a number of stocks expressing GAL4 in
various spatial and temporal patterns throughout develop-
ment, and the progeny from these crosses were analyzed for
phenotypes dependent on RasGAP expression.
Signaling through Ras1 and RTKs has been particularly ex-
tensively studied in the Drosophila eye, but we found that over-
expression of RasGAP in the eye-antennal imaginal disc with
eyeless (ey)-GAL4 or GMR-GAL4 lines did not cause any de-
tectable phenotype (24). Furthermore, expression of RasGAP
with the sevenless (sev) enhancer did not affect photoreceptor
differentiation in otherwise wild-type flies nor did it suppress
the sevenless gain-of-function allele, sevS11 (4, 24). It is known
from genetic studies that Gap1, a related but distinct putative
GAP, inhibits Ras1 signaling in the eye-antennal disc (30). Al-
ready high-level expression of Gap1 might explain the insen-
sitivity of this tissue to overexpression of RasGAP.
Another adult tissue known to require Ras1 function during
its development is the wing. Therefore we expressed high levels
of RasGAP in the wing imaginal disc with the MS-1096 GAL4
line, which drives expression throughout the disc with highest
levels in the dorsal pouch (9). This resulted in a decrease in the
FIG. 3. GAP activity of RasGAP. (A) Expression of full-length RasGAP in
S. pombe. Cell extracts prepared from a gap1 mutant strain transformed with
pREPRasGAP (lane 1) or a vector control (lane 2) were subjected to SDS-PAGE
and Western blotted with an anti-RasGAP polyclonal antibody (a-RasGAP).
Expression of the full-length RasGAP protein migrating close to the predicted
molecular weight (108 kDa) can be detected in lane 1. Migration of molecular
weight markers (in kilodaltons) is shown. (B) The RasGAP and vector cell
extracts were assayed for GAP activity on wild-type H-Ras (hatched bars) or
Val12 H-Ras (filled bars); a control assay without extract was done to determine
the intrinsic GTPase activity of the Ras proteins. The percent GTP remaining
after a 15-min incubation was measured and plotted in a bar graph. Error bars
show standard deviations of assays done in triplicate. Results are representative
of three independent experiments.
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size of the adult wing and an upward curvature of the wing
blade, presumably because the dorsal surface of the wing was
more strongly affected than the ventral surface (Fig. 5 and
Table 1). With the strongest-expressing UAS-RasGAP line
(line 1), wings from males were about 45% smaller than the
wings from control flies not carrying the transgene, whereas
the wings of females were reduced in size by 10 to 20%. The
difference between males and females can be explained by the
fact that GAL4 is expressed from the X chromosome in the
MS-1096 line and will be subject to dosage compensation in
males. This suggests that the reduction in wing size caused by
ectopic RasGAP expression is dosage sensitive, and we ob-
served that the two lines expressing RasGAP at a lower level
(lines 2 and 3) had a correspondingly lesser effect on wing size
(Table 1).
A decrease in wing size could be the result of a decrease in
cell number or a decrease in cell size or a combination of both
effects. Each cell on the wing blade produces a single hair so
that measuring the density of hairs gives a measure of cell size.
However, it was difficult to measure surface areas accurately
because the curvature of the wing blade caused folding of the
wing surface when mounted on slides for microscopy. This
effect was less pronounced at the wing margins so the number
of hairs (and therefore cells) on the dorsal margin of the wing
between longitudinal veins LIII and LIV was counted and
the length of the wing margin measured. Ectopic expression
of RasGAP led to a reduction in the number of hairs from
19.50 6 0.95 to 16.33 6 0.47 in females of line 1 (mean 6
FIG. 4. Characterization of RasGAP and interacting proteins. (A) Developmental expression of RasGAP protein. Equal amounts of total cell lysates from embryos
(0 to 18 h) (Em), mixed-stage larvae (L), and adults (Ad) were Western blotted with anti-RasGAP monoclonal antibody. A control lysate (Ct) was made from adult
flies expressing a heat-shock-inducible RasGAP transgene after heat shock for 1 h at 37°C. (B) Tyrosine phosphorylation of RasGAP in vivo. RasGAP was
immunoprecipitated from embryonic extracts and Western blotted with either an anti-RasGAP polyclonal antibody (a-RasGAP) or a monoclonal antiphosphotyrosine
antibody (a-pTyr). Migration of molecular weight markers (in kilodaltons) is shown. (C) In vitro association of the SH2 domains of RasGAP with tyrosine-
phosphorylated proteins from different developmental stages. Extracts were prepared from 0 to 4-h embryos (Em1), 12- to 24-h embryos (Em2), mixed-stage larvae
(L), pupae (P), and adult females (Ad). The wild-type GST-SH232 or mutant GST-SH2*32* fusion proteins bound to glutathione-Sepharose were used to precipitate
proteins which were subsequently Western blotted with the antiphosphotyrosine antibody. (D) Immunostaining of precellularized embryo with anti-RasGAP
monoclonal antibody showing early expression of RasGAP protein during embryonic development. (E) Immunostaining of cellularized blastoderm embryo showing
cytoplasmic localization of RasGAP protein.
FIG. 5. Ectopic expression of RasGAP in the wing imaginal disc leads to a
decrease in size of the adult wing. GAL4 and RasGAP were expressed in the
dorsal pouch of the wing with the MS-1096 GAL4 line. The genotypes are GAL4/1
(A), GAL4/1 UAS-RasGAP/1 (B), GAL4/Y (C), and GAL4/Y UAS-RasGAP/1
(D). (A and B) Wings from females; (C and D) wings from males. Bar, 250 mm.
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standard deviation [SD]), without significantly affecting cell
diameter along the wing margin (14.2 mm in controls and
14.8 mm in RasGAP-expressing females). From these mea-
surements, we attribute the small wing phenotype primarily to
a decrease in cell number rather than cell size, although we
cannot rule out the possibility that cell size is affected in other
parts of the wing.
From the in vitro biochemical properties and effect of its
expression in S. pombe it seemed likely that the effect of ec-
topic RasGAP expression on growth of the wing imaginal disc
was the result of downregulating the activity of Ras1, the Dro-
sophila homolog of mammalian Ras proteins. It is known that
decreasing the strength of signaling through the Ras1–mito-
gen-activated protein kinase (MAPK) pathway can inhibit pro-
liferation of wing disc cells causing a reduction in adult wing
size (18). If inhibition of Ras1 function was responsible for the
small wing phenotype caused by RasGAP overexpression then
lowering the Ras1 gene dosage would be expected to enhance
the small wing phenotype. However, we found that heterozy-
gosity for Ras1 did not enhance the RasGAP-induced small
wing phenotype: in this experiment the wings from GAL4(MS-
1096) UAS-RasGAP females were 80.6 6 2.3% and wings from
GAL4(MS-1094) UAS-RasGAP Ras1/1 females were 81.7 6
3.1% the size of GAL4(MS-1096) UAS-lacZ controls.
Downregulation of receptor tyrosine kinase signaling by ec-
topic RasGAP expression. Inhibition of the Ras1-MAPK path-
way also disrupts the formation of wing veins, a process that
requires the Drosophila EGF receptor homolog (DER) (18).
Ectopic expression of RasGAP, however, did not disrupt the
longitudinal wing veins (Fig. 5B and D). (Loss of the anterior
cross vein as seen in Fig. 5D is also seen at a variable frequency
in males hemizygous for the MS-1096 GAL4 insertion but not
carrying UAS-RasGAP.) However, differentiation of wing veins
occurs during the pupal stage when the level of expression
from the MS-1096 GAL4 line might be lower than during the
larval stages (11).
To investigate the effect of RasGAP overexpression on wing
vein differentiation in a genetically sensitized system we exam-
ined whether RasGAP overexpression could suppress the ec-
topic veins caused by gain-of-function mutations in RTKs or by
overexpression of Ras1. Activated mutants of the EGF recep-
tor homolog DER and the fibroblast growth factor (FGF)
receptor homologs encoded by the breathless (btl) and heartless
(htl) genes have been made by fusing their intracellular part
carrying the tyrosine-kinase catalytic domain to the extracellu-
lar and membrane-spanning domains of a gain-of-function
torso mutant, tor4021 (57). At 25°C no adult flies eclosed when
UAS constructs of Tor4021-DER, Tor4021 itself, or Ras1 were
expressed under control of the MS-1096 GAL4 line; at 18°C a
few adult flies expressing these UAS constructs eclosed but had
wings that were too abnormal to analyze further (24). Expres-
sion of activated Tor4021-btl or Tor4021-htl, however, gave a
phenotype characteristic of activation of the DER-Ras1-MAPK
pathway: extra wing vein material and “deltas” at the wing mar-
gins were present and the wings were larger (Fig. 6A and C).
Coexpression of RasGAP suppressed the formation of extra
wing vein material and reduced the size of the wings (Fig. 6B
and D). These effects required the SH2 domains of RasGAP
because we found that expression of the RasGAPSH2* mu-
tant, with inactivating substitutions in both SH2 domains,
was unable to suppress the activated FGF receptor phenotypes
(Fig. 6E). The RasGAPSH2* mutant also failed to inhibit wing
growth when expressed alone, showing that this effect also re-
quires intact SH2 domains (24). Consistent with signaling from
the FGF receptors leading to Ras1 activation, heterozygosity
for a Ras1 loss-of-function mutation suppressed the extra wing
vein material caused by ectopic RTK expression (Fig. 6F), though
not as efficiently as RasGAP overexpression. These results show
that RasGAP can attenuate activation of the Ras1-MAPK path-
way by the Breathless and Heartless RTKs, presumably by in-
hibiting the accumulation of Ras1-GTP, and that the SH2 do-
mains of RasGAP are essential for its ability to inhibit both
RTK signaling and wing growth.
DISCUSSION
The p120 Ras-GAP homolog we have identified, RasGAP, is
the third GAP for Ras proteins to be identified in Drosophila
and shows that this invertebrate has one of each of the types of
RasGAPs found in mammals (30, 62). The most conserved
region of the protein encompasses the SH2 and SH3 protein-
protein interaction domains in the amino-terminal adapter-
like region, which is 57% identical in amino acid sequence be-
tween the Drosophila and human proteins. The SH2 domains
of mammalian p120 Ras-GAP mediate binding to certain
FIG. 6. Ectopic expression of RasGAP inhibits signaling by activated FGF
receptor homologs (Breathless and Heartless) in the wing. The genotypes are
GAL4/1 UAS-tor4021-btl/1 (A), GAL4/1 UAS-tor4021-btl/1 UAS-RasGAP/1
(B), GAL4/1 UAS-tor4021-htl/1 (C), GAL4/1 UAS-tor4021-htl/1 UAS-RasGAP/
1 (D), GAL4/1 UAS-tor4021-htl/1 UAS-RasGAPSH2*/1 (E), and GAL4/1
UAS-tor4021-htl/1 Ras1e2F/1 (F). The GAL4 line was MS-1096. Bar, 250 mm.
TABLE 1. Effect of RasGAP expression on wing size
Transgenic
linea
Wing area (mm2)b Wing area(% of control)
Male Female Male Female
Control 1.48 6 0.02 1.49 6 0.05 100 100
Line 1 0.80 6 0.04 1.09 6 0.04 54.7 77.9
Line 2 1.03 6 0.02 1.30 6 0.04 69.9 87.2
Line 3 NDc 1.29 6 0.05 ND 86.7
a The transgenic lines were hemizygous (males) or heterozygous (females) for
the MS-1096 GAL4 insertion on the X chromosome. Lines 1 and 2 carry inde-
pendent insertions of UAS-RasGAP on the second chromosome; line 3 was
heterozygous for UAS-RasGAP insertions on the second and third chromosomes.
b Values are means 6 SD (n 5 4).
c ND, not determined.
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RTKs, p190 Rho-GAP, and the docking protein p62dok (see
the introduction). In work described elsewhere we show that
the SH2 domains of RasGAP bind in vitro to an autophos-
phorylation site on Torso (14), a RTK required during early
embryonic development (61). The sequences surrounding the
phosphotyrosine residue (phosphoYLEP) on Torso match the
optimal binding site for the SH2 domains of mammalian p120
Ras-GAP (38, 39). The RasGAP SH2 domains bind in vitro to
a small number of tyrosine-phosphorylated proteins from dif-
ferent developmental stages. Whether these are RTKs and the
Drosophila homologs of p190 Rho-GAP and p62dok remains
to be established.
One notable difference between RasGAP and the mamma-
lian p120 Ras-GAP isoform is that the latter has a proline-rich
sequence near the amino terminus which is absent in the Dro-
sophila protein. This region appears to be required for in vitro
association of p120 Ras-GAP with Src family tyrosine kinases
(Src, Hck, Lck, and Fyn) via their SH3 domain (7) and could be
involved in the in vivo association of p120 Ras-GAP with Src
family tyrosine kinases (13). Drosophila RasGAP also lacks
an ;70-amino-acid hydrophobic region found at the amino
terminus of p120 Ras-GAP. The p100 Ras-GAP isoform ex-
pressed in placenta does not have the polyproline region or a
hydrophobic amino terminus (65).
We have begun to study the function of RasGAP in vivo
by ectopic expression of the full-length protein in the wing
imaginal disc with the GAL4-UAS system. Overexpression of
RasGAP inhibits growth of the wing, resulting in a decrease in
size of the adult wing of up to 45% as a consequence of having
fewer rather than smaller cells. This suggests that RasGAP
overexpression reduces the rate of proliferation or increases
the rate of apoptosis in the wing imaginal disc. Is this effect due
to inhibition of Ras1 function? This could occur either by
reducing the amount of Ras1-GTP, which would be consistent
with the biochemical properties of RasGAP in vitro, or by
competition between RasGAP and Ras1 effectors for binding
to Ras1-GTP.
The ability of RasGAP to suppress ectopic wing vein forma-
tion caused by hyperactivation of the Breathless and Heartless
FGF receptor homologs strongly suggests that RasGAP can
indeed downregulate Ras1 activation by these RTKs. Both
Drosophila FGF receptors have exact matches to the optimal
binding site (phospho YxxPxD, where x is any amino acid) for
the SH2 domains of mammalian p120 Ras-GAP (38, 39). Giv-
en our demonstration in this study that the SH2 domains of
RasGAP are essential for its activity in vivo it is likely that the
activated FGF receptors directly recruit RasGAP to the plas-
ma-membrane where it is well placed to interact with its sub-
strate, Ras1-GTP.
The DER-Ras1-MAPK pathway regulates both cell prolif-
eration and wing vein differentiation in the wing disc (18). It
was puzzling, therefore, why RasGAP overexpression did not
affect wing vein formation in otherwise wild-type flies. One
possible explanation is that the MS-1096 GAL4 line does not
drive sufficient expression of RasGAP in the pupal disc when
vein differentiation occurs. However, the ectopic veins caused
by the activated FGF receptors were efficiently suppressed
by coexpression of RasGAP. We favor the explanation that
RasGAP is not efficiently recruited to the plasma membrane by
the DER RTK, and this is consistent with our failure to detect
an effect of RasGAP overexpression on photoreceptor devel-
opment in the eye, a process controlled by the DER and Sev
RTKs, neither of which contains the RasGAP SH2 binding
consensus. The insulin receptor (Inr), another RTK, is also im-
plicated in the control of cell proliferation in the wing disc (12,
25), but we did not see any enhancement of the RasGAP over-
expression phenotype in flies heterozygous for an inr mutation
(24). The insensitivity of the RasGAP-induced small wing phe-
notype to the gene dosage of Ras1 suggests that RasGAP could
be inhibiting proliferative signals that are not dependent on
Ras1.
One important and unresolved issue is the specificity of
RasGAPs in vivo. Mammalian p120 Ras-GAP can act as a
GAP in vitro for the Ras-related protein R-Ras (29), and also,
more surprisingly, for the much more distantly related small
GTPase Rab5 (43), which is involved in the regulation of en-
docytosis. A further twist is that the Ras-related protein Rap1/
Krev-1 binds to p120 Ras-GAP with high affinity but is not a
substrate (27). Drosophila homologs of R-Ras (Ras2), Rap1
(Roughened), and Rab5 (Drab5) have been identified (34, 52,
58). Their roles in imaginal disc growth and differentiation are
not clear, although it has been observed that expression of a
constitutively active Ras2 mutant in the wing disc gives rise to
ectopic veins (6, 17). Therefore, it is possible that some of the
effects of RasGAP overexpression are the consequence of in-
teractions with Ras2, Roughened, or Drab5.
Alternatively, the functions of proteins that interact with the
amino-terminal adapter region of RasGAP may be affected
by RasGAP overexpression and cause growth inhibition.
However, overexpressing just the SH2-SH3-SH2 region of
RasGAP by using the same UAS-GAL4 system does not
affect wing growth (24). Further studies of the effects of ex-
pressing RasGAP transgenes with mutations in the modular
domains and the isolation of RasGAP mutants should help to
clarify the physiological roles of this important signaling pro-
tein. The extensive structural and functional similarities be-
tween the Drosophila and mammalian RasGAPs indicates that
insights gained from genetic approaches in flies will also be
relevant to the role of p120 Ras-GAP in mammals.
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